Published in TB and Outbreaks Week, July 22nd, 2003
The finding, which appeared online June 30, 2003, in Proceedings of the National Academy of Sciences, could lead to the development of beta blockers as a therapy to impede this cellular signaling system, causing the harmful bacteria to pass blindly through the digestive tract, said Dr. Vanessa Sperandio, lead author of the study.
"You're not really attacking the bacteria per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.